首页> 美国卫生研究院文献>Biology >Development of a Pulsatile Flow-Generating Circulatory Assist Device (K-Beat) for Use with Veno-Arterial Extracorporeal Membrane Oxygenation in a Pig Model Study
【2h】

Development of a Pulsatile Flow-Generating Circulatory Assist Device (K-Beat) for Use with Veno-Arterial Extracorporeal Membrane Oxygenation in a Pig Model Study

机译:开发脉动流动产生循环辅助装置(K-BEAK)用于猪模型研究中的静脉动脉体外膜氧合

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Veno-arterial extracorporeal membrane oxygenation (V-A ECMO) preserves the life of heart failure patients by providing an adequate oxygen supply and blood flow to vital organs. For patients with severe cardiogenic shock secondary to acute myocardial infarction or acute myocarditis, V-A ECMO is commonly used as the first choice among cardiac circulatory support devices. While V-A ECMO generates circulatory flow using a centrifugal pump, the provision of pulsatile flow is difficult. We previously reported our development of a new circulatory flow assist device (K-beat) for cardiac management with pulsatile flow. To obtain more efficient pulsatile assist flow (diastolic augmentation), an electrocardiogram (ECG)-analyzing device that can detect R waves and T waves increases the assist flow selectively in the diastole phase by controlling (opening and closing) the magnetic valve of the tamper. Here, we describe the first use of the K-beat on a large animal in combination with a clinical device. In addition, the diastolic augmentation effect of the K-beat as a circulatory flow assist device was examined in a pig V-A ECMO model. The K-beat was stopped every 60 min for a period of a few minutes, and blood pressure waveforms in the pulsatile and non-pulsatile phases were checked. This experiment showed that stable V-A ECMO could be achieved and that hemodynamics were managed in all animals. The pulsatile flow was provided in synchrony with the ECG in all cases. A diastolic augmentation waveform of femoral arterial pressure was confirmed in the pulsatile phase. K-beat could be useful in patients with severe heart failure.
机译:静脉动脉体外膜氧合(V-A ECMO)通过为重要器官提供足够的氧气供应和血流来保留心力衰竭患者的寿命。对于患有严重的心肌梗死患者,急性心肌梗死或急性心肌炎,V-A ECMO通常用作心脏循环支撑装置的第一选择。虽然V-A ECMO使用离心泵产生循环流量,但难以提供脉动流。我们以前报道了我们开发了一种新的循环流动辅助装置(K-BEET),用于具有脉动流动的心脏管理。为了获得更高效的脉动辅助流(舒张压),可以检测R波和T波的心电图(ECG) - 分析装置通过控制(打开和关闭)夯实的磁阀(打开和闭合)通过控制(打开和闭合)来增加辅助流动。在这里,我们描述了与临床装置组合的大型动物在大型动物上的第一次使用。此外,在猪V-A ECMO模型中检查了K-BEAK作为循环流动辅助装置的舒张增强效果。每60分钟停止k次k-ey持续几分钟的时间,检查脉动和非脉动相的血压波形。该实验表明,可以实现稳定的V-A ECMO,并且在所有动物中管理血流动力学。在所有情况下,脉动流量与ECG同步提供。在脉动相中证实了股动脉压的舒张压波形。 K-Beat可用于严重心力衰竭的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号